7600 Japan Medical Dynamic Marketing, INC. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

7600

TSE Prime

Japan Medical Dynamic Marketing, INC.

574

JPY

-4

(-0.69%)

Dec 23, 3:30 pm JST

3.66

USD

Dec 23, 1:30 am EST

Result

PTS

outside of trading hours

555

Dec 23, 8:15 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	16,738	2,168	2,125	1,664	63.1	11	Apr 30, 2021	J-GAAP
Mar, 2022	19,193	2,661	2,591	2,135	81.0	12	Apr 28, 2022	J-GAAP
Mar, 2023	21,307	2,024	2,043	1,423	54.0	13	Apr 28, 2023	J-GAAP
Mar, 2024	23,177	1,746	1,842	1,271	48.3	14	Apr 30, 2024	J-GAAP
Mar, 2025 Guidance	25,200	1,850	1,850	1,300	49.4	15	Apr 30, 2024	J-GAAP
YoY	+8.7%	+6.0%	+0.4%	+2.3%	+2.2%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	Apr 26, 2019	18,200	2,460	2,380	1,720	10	J-GAAP
	Oct 31, 2019	18,750	2,850	2,770	2,050	10	J-GAAP
Results	Apr 30, 2020	18,083	2,644	2,581	2,164	10	J-GAAP
Mar, 2021	Apr 30, 2020	Available in future release
	Oct 23, 2020
Results	Apr 30, 2021
Mar, 2022	Apr 30, 2021
Results	Apr 28, 2022
Mar, 2023	Apr 28, 2022
	Oct 31, 2022
Results	Apr 28, 2023
Mar, 2024	Apr 28, 2023
	Oct 30, 2023
Results	Apr 30, 2024
Mar, 2025	Apr 30, 2024	25,200	1,850	1,850	1,300	15	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
May, 2000	10,900	+13.2	Available in future release
May, 2001	11,727	+7.6
May, 2002	12,658	+7.9
May, 2003	13,944	+10.2
May, 2004	13,736	-1.5
May, 2005	13,391	-2.5
May, 2006	12,901	-3.7
May, 2007	11,462	-11.2
May, 2008	11,447	-0.1
May, 2009	10,394	-9.2
May, 2010	9,894	-4.8
May, 2011	9,531	-3.7
Mar, 2012 Changed	8,120	－
Mar, 2013	8,134	+0.2
Mar, 2014	9,459	+16.3
Mar, 2015	11,855	+25.3
Mar, 2016	13,024	+9.9
Mar, 2017	13,629	+4.6
Mar, 2018	14,807	+8.6
Mar, 2019	16,728	+13.0
Mar, 2020	18,083	+8.1
Mar, 2021	16,738	-7.4
Mar, 2022	19,193	+14.7
Mar, 2023	21,307	+11.0
Mar, 2024	23,177	+8.8
Mar, 2025 Guidance	25,200	+8.7	1,850	+6.0	1,850	+0.4	49.4	+2.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	21,307	2,024	9.50	6.39	5.01	0.75	54.0
Mar, 2024	23,177	1,746	7.53	5.22	4.17	0.76	48.3
Mar, 2025 Guidance	25,200	1,850	7.34	5.24	4.17	0.81	49.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	23,177	4,068	3,763	2,164	106.4
Fiscal Year	Mar, 2024	May, 2003	May, 2004	Mar, 2020	May, 2004

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	10,335	1,603	1,549	1,132	42.9	12	Apr 28, 2022	J-GAAP
Oct - Mar, 2022	11,318	1,097	1,127	702	26.7	13	Apr 28, 2023	J-GAAP
Oct - Mar, 2023	12,225	1,129	1,210	912	34.7	14	Apr 30, 2024	J-GAAP
Oct - Mar, 2024 Guidance	13,383	1,181	1,186	804	30.5	15	Oct 30, 2024	J-GAAP
YoY	+9.5%	+4.6%	-2.0%	-11.8%	-11.9%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	2,661	1,361	3,111	-1,750	-1,287	2,590	9.47	J-GAAP
Mar, 2023	2,024	705	2,186	-1,481	-514	2,804	9.53	J-GAAP
Mar, 2024	1,746	300	2,104	-1,804	-840	2,321	7.37	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	9,989	927	916	721	27.4	44.8	Oct 31, 2022	J-GAAP
Apr - Sep, 2023	10,952	617	632	359	13.7	34.3	Oct 30, 2023	J-GAAP
Apr - Sep, 2024	11,817	669	664	496	18.9	35.9	Oct 30, 2024	J-GAAP
YoY	+7.9%	+8.4%	+5.1%	+38.2%	+37.9%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	5,635	583	627	417	15.8	10.3	Jan 31, 2023	J-GAAP
Jan - Mar, 2023	5,683	514	500	285	10.8	9.0	Apr 28, 2023	J-GAAP
Apr - Jun, 2023	5,402	346	337	177	6.7	6.4	Jul 28, 2023	J-GAAP
Jul - Sep, 2023	5,550	271	295	182	6.9	4.9	Oct 30, 2023	J-GAAP
Oct - Dec, 2023	6,041	566	593	373	14.2	9.4	Jan 31, 2024	J-GAAP
Jan - Mar, 2024	6,184	563	617	539	20.5	9.1	Apr 30, 2024	J-GAAP
Apr - Jun, 2024	6,052	366	367	273	10.4	6.0	Jul 30, 2024	J-GAAP
Jul - Sep, 2024	5,765	303	297	223	8.5	5.3	Oct 30, 2024	J-GAAP
YoY	+3.9%	+11.8%	+0.7%	+22.5%	+22.2%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	4,725	+5.2	Available in future release
Jan - Mar, 2020	4,576	-2.4
Apr - Jun, 2020	3,409	-21.9
Jul - Sep, 2020	4,344	-1.7
Oct - Dec, 2020	4,555	-3.6
Jan - Mar, 2021	4,430	-3.2
Apr - Jun, 2021	4,537	+33.1
Jul - Sep, 2021	4,321	-0.5
Oct - Dec, 2021	5,120	+12.4
Jan - Mar, 2022	5,215	+17.7
Apr - Jun, 2022	5,027	+10.8
Jul - Sep, 2022	4,962	+14.8
Oct - Dec, 2022	5,635	+10.1
Jan - Mar, 2023	5,683	+9.0
Apr - Jun, 2023	5,402	+7.5
Jul - Sep, 2023	5,550	+11.9
Oct - Dec, 2023	6,041	+7.2
Jan - Mar, 2024	6,184	+8.8
Apr - Jun, 2024	6,052	+12.0
Jul - Sep, 2024	5,765	+3.9	303	+11.8	297	+0.7	8.5	+23.2

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	6,184	1,213	1,258	852	37.2
Fiscal Year	Mar, 2024	Feb, 2003	Feb, 2003	Mar, 2019	Feb, 2003

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	810.59	78.2	27,342	21,386	14,550	0.09	Apr 28, 2022	J-GAAP
Mar, 2023	880.64	78.7	29,434	23,161	15,656	0.08	Apr 28, 2023	J-GAAP
Mar, 2024	968.74	81.0	31,485	25,511	16,583	0.06	Apr 30, 2024	J-GAAP
Apr - Sep, 2024	ー	79.6	31,162	24,819	16,710	0.10	Oct 30, 2024	J-GAAP

Japan Medical Dynamic Marketing, INC.(7600) Financial Results